In obesity research and clinical practice, disease progress or response to therapy is typically evaluated by the reduction of body weight, adipose tissue (AT) volume or comorbidity remission rates. However, little is currently known about therapy-induced changes in subcutaneous and visceral AT composition and how to quantify them. Lean control subjects had recently been shown to have significantly higher T1 relaxation times in both SAT (301 ms) and VAT (360 ms) than severely obese patients (275 and 294 ms, respectively). Aims of this study were to characterize AT by quantitative MRI and evaluate the intra-individual changes at two time points.
This abstract and the presentation materials are available to members only; a login is required.